API 0.74% $1.35 australian pharmaceutical industries limited

Page 59 is what you should be looking at. Their heavy use of...

  1. 52 Posts.
    Page 59 is what you should be looking at. Their heavy use of revolving facilities to fund their working capital means their period end BS number is worthless.

    First clue is they had 13m of net finance costs on average BS net debt of ~19m. Year before they had average BS figure of 48m and interest of 16m.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.